Single and dual blockade of the renin-angiotensin system in high-risk patients without heart failure: Lessons from ONTARGET Paolo VerdecchiaFabio AngeliGianpaolo Reboldi Invited Commentary 23 November 2008 Pages: 417 - 419
The neurobiology and treatment of tobacco dependence Thomas A. NguyenRobert M. Anthenelli OriginalPaper 23 November 2008 Pages: 427 - 433
How smokeless tobacco differs from smoking and nicotine replacement therapy Ziad Arabi OriginalPaper 23 November 2008 Pages: 439 - 445
Smoking and inflammation: Their synergistic roles in chronic disease Bente HalvorsenKari OtterdalPål Aukrust OriginalPaper 23 November 2008 Pages: 446 - 451
Community resources for smoking cessation Ernestine G. JenningsDori PekmeziBess Marcus OriginalPaper 23 November 2008 Pages: 452 - 457
Randomized trial of genotype-guided versus standard warfarin dosing in patients initiating oral anticoagulation J. Gustav SmithChristopher Newton-Cheh Clinical Trials Report 23 November 2008 Pages: 461 - 462
Genetic mechanisms of mitral valve prolapse Susan A. SlaugenhauptRobert A. LevineVincent Probst OriginalPaper 23 November 2008 Pages: 463 - 467
Genetic determinants of responsiveness to antiplatelet therapy Brian G. KralLookman LawalLewis C. Becker OriginalPaper 23 November 2008 Pages: 476 - 484
Genetic determinants of drug response in heart failure Brian D. LowesPeter M. Buttrick OriginalPaper 23 November 2008 Pages: 485 - 490